ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BX06 | BioTech | Emicizumab - 30mg/ml | 9903/388 | 101818/1 | HEMLIBRA | 30mg/ml | 1x1ml | Injectable solution | SC | Omnipharma | Chugai Pharma Manufacturing Co Ltd | Japan | L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BX06 | BioTech | Emicizumab - 30mg/ml | 9903 | 101818/1 | HEMLIBRA | 30mg/ml | 1x1ml | Injectable solution | SC | Omnipharma | Chugai Pharma Manufacturing Co Ltd | Japan | 224,585,721 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |